Coupled recognition/detection system for in vivo and in vitro use

Patent metadata

Field	Value
Publication number	US-10316000-B2
Application number	US-201013202250-A
Country	US
Kind code	B2
Filing date	Feb 18, 2010
Priority date	Feb 18, 2009
Publication date	Jun 11, 2019
Grant date	Jun 11, 2019

Abstract

The present invention relates to novel fluorophores and their use in combination with novel nucleic acid molecules, called aptamers, that bind specifically to the fluorophore and thereby enhance the fluorescence signal of the fluorophore upon exposure to radiation of suitable wavelength. Molecular complexes formed between the novel fluorophores, novel nucleic acid molecules, and their target molecules are described, and the use of multivalent aptamer constructs as fluorescent sensors for target molecules of interest are also described.

First claim

What is claimed:

1. A molecular complex comprising:
(a) an imidazolinone fluorophore selected from the group consisting of 4-(3,5-dimethoxy-4-hydroxybenzylidene)-1,2-dimethoxy-imidazole-5-one (DMHBI), 3,5-difluoro-4-hydroxybenzylidene-1,2-dimethyl-imidizolan-5-one (DFHBI), 4-(4-dimethylamino)benzylidene)-1,2-dimethyl-imidazol-5-one (DMABI), and 4-(2-hydroxybenzylidene)-1,2-dimethyl-imidazole-5-one (o-HBDI); and
(b) a nucleic acid aptamer molecule comprising, a first domain having a secondary structure, wherein the nucleic acid aptamer molecule binds specifically and directly to the imidazolinone fluorophore to form the molecular complex, such that upon exposure to radiation of a suitable wavelength, the imidazolinone fluorophore exhibits fluorescence that is enhanced as compared to fluorescence by the imidazolinone fluorophore in the absence of specific and direct binding by the nucleic acid aptamer molecule, such that:
(i) when the imidazolinone fluorophore is DMHBI, the nucleic acid aptamer molecule that binds specifically and directly to the imidazolinone fluorophore to form the molecular complex is selected from the group consisting of SEQ ID NOS: 34-39 and 57-61;
(ii) when the imidazolinone fluorophore is DFHBI, the nucleic acid aptamer molecule that binds specifically and directly to the imidazolinone fluorophore to form the molecular complex is selected from the group consisting of SEQ ID NOS: 42-44;
(iii) when the imidazolinone fluorophore is DMABI, the nucleic acid aptamer molecule that binds specifically and directly to the imidazolinone fluorophore to form the molecular complex is selected from the group consisting of SEQ ID NOS: 45-51; and
(iv) when the imidazolinone fluorophore is o-HBDI, the nucleic acid aptamer molecule that binds specifically and directly to the imidazolinone fluorophore to form the molecular complex is selected from the group consisting of SEQ ID NOS: 52-55.

2. The molecular complex according to claim 1 , wherein the nucleic acid aptamer molecule further comprises a second domain that binds specifically to a target molecule that is distinct from the imidazolinone fluorophore.

3. The molecule complex according to claim 2 , wherein the first domain binds to the imidazolinone fluorophore only after binding of the second domain to the target molecule, the molecular complex further comprising the target molecule bound by the second domain.

4. A host cell containing the molecular complex according to claim 1 .

5. The molecular complex according to claim 1 , wherein the nucleic acid aptamer molecule comprises a plurality of the first domains that bind the imidazolinone fluorophore.

6. The molecular complex according to claim 2 , wherein the nucleic acid aptamer molecule comprises a plurality of the first domains that each bind to the imidazolinone fluorophore.

7. The molecular complex according to claim 2 , wherein the nucleic acid aptamer molecule comprises a plurality of first and second domain concatemers.

8. The molecular complex according to claim 2 , wherein the nucleic acid aptamer molecule comprises a nucleotide sequence selected from the group consisting of SEQ ID NO: 31, SEQ ID NO: 32, and SEQ ID NO: 33.

9. The molecular complex according to claim 3 , wherein the target molecule is selected from the group consisting of adenosine triphosphate, cyclic guanosine monophosphate, biotin, nicotinamide, and nicotinamide adenine dinucleotide.

10. The molecular complex according to claim 3 , wherein the target molecule is selected from the group consisting of proteins, nucleic acids, lipids, carbohydrates, hormones, cytokines, chemokines, metabolites, organic molecules, and metal ions.

11. The molecular complex according to claim 1 , wherein the imidazolinone fluorophore is 3,5-difluoro-4-hydroxy-benzylidene-1,2-dimethyl-imidizolan-5-one.

Assignees

• Jaffrey Samie R
• Paige Jeremy S
• Univ Cornell

Inventors

• Jaffrey Samie R
• Paige Jeremy S

Classifications

• A61K49/0032

  Methine dyes, e.g. cyanine dyes · CPC title

• C07D233/96 Primary

  having three double bonds between ring members or between ring members and non-ring members · CPC title

• C09B23/04

  one >CH- group, e.g. cyanines, isocyanines, pseudocyanines · CPC title

• A61K49/0054

  Macromolecular compounds, i.e. oligomers, polymers, dendrimers · CPC title

• C07D403/06

  linked by a carbon chain containing only aliphatic carbon atoms · CPC title